The effective S-1 opens the door for a dilutive offering at any time. Given the $5M market cap and poor historical returns on APVO events, traders should expect near-term share price pressure. Monitor for a prospectus supplement (424B) to see the actual offering size and pricing — any raise above ~$1M would be highly dilutive.
Price Chart
Executive Summary
Aptevo Therapeutics Inc. (APVO) filed an EFFECT notice on 2026-09-02, indicating that its S-1 registration statement (File No. 333-298483) has been declared effective by the SEC. This allows the company to proceed with a securities offering, which for a micro-cap biotech with a $5M market cap typically signals imminent dilution. The cross-filing actuarial verdict confirms this as an amplifier for the IPO-context + shelf-context combination, reinforcing the bearish dilution overhang for existing shareholders.
Key Facts
- Aptevo Therapeutics' S-1 registration (File No. 333-298483) became effective on 2026-09-02.
- The company can now sell securities under the 1933 Act, creating a potential dilution overhang.
- Market cap is only $5M, making any offering size material relative to existing equity.
Financial Impact
Dilution from the now-effective S-1 offering; exact terms (size, price) are undisclosed but likely significant relative to the $5M market cap.
Risk Factors
- Imminent dilutive offering could significantly reduce per-share value for existing holders.
- Micro-cap biotech with no disclosed revenue or pipeline catalysts; offering proceeds may not be sufficient to reach key milestones.
- Historical pattern of negative returns on APVO events suggests the market consistently prices in downside.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002871 |
| Document: 9999999995-26-002871-index.html | 9999999995-26-002871 |
| Document: 9999999995-26-002871.txt | 9999999995-26-002871 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | 8-K | $1.73 | awaiting T+5 | — | $1.28 (−26.09%) |
Oct 23, 2026 3d ago | 8-K | $1.61 | awaiting T+5 | — | $1.28 (−20.50%) |
Oct 14, 2026 13d ago | 8-K | $1.73 $1.60 | ▼ −7.51% | ▼ −7.97% | $1.28 (−26.01%) |
Sep 24, 2026 4w ago | 8-K | $1.83 $1.76 | ▼ −3.83% | ▼ −3.41% | $1.28 (−30.05%) |
Sep 3, 2026 7w ago | 424B4 / 8-K | $1.71 $1.82 | ▲ +6.43% | ▲ +7.58% | $1.28 (−25.15%) |
Sep 3, 2026 7w ago | EFFECT | $1.71 $1.82 | ▼ −6.43% | ▼ −7.58% | $1.28 (+25.15%) |
Aug 14, 2026 10w ago | 8-K | $2.94 $2.68 | ▼ −8.84% | ▼ −7.48% | $1.28 (−56.46%) |
Jul 27, 2026 13w ago | 8-K | $4.21 $3.95 | ▼ −6.18% | ▼ −8.44% | $1.28 (−69.60%) |
Jun 30, 2026 16w ago | 8-K | $4.45 $4.51 | ▲ +1.35% | ▲ +1.09% | $1.28 (−71.24%) |
May 6, 2026 24w ago | 8-K | $4.86 $4.76 | ▼ −2.06% | ▼ −3.56% | $1.28 (−73.66%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers